Primal Grow Pro Ingredients: All Seven Names, And What Each One Carries

Leaf extract from a tree that has been in continuous cultivation longer than most countries have existed, and the most thoroughly trialled name on this label by a wide margin. The standardised preparations used in research are specified by two marker groups, flavone glycosides and terpene lactones, and the trials ran at 120 to 240 mg a day split across two or three servings.

The circulation evidence is the reason it sits under that support. The Cochrane review of ginkgo in intermittent claudication pooled trials measuring pain-free walking distance in people with narrowed leg arteries, which is about as physical a circulatory endpoint as a supplement gets measured against. The pooled result showed no meaningful advantage over placebo. That is a real finding rather than a silence, and it is the sort of thing a buyer is better off knowing.

In this product's own territory the record is friendlier. A systematic review of ginkgo and sexual function collects the human trials, two of which were run in people whose difficulty was linked to antidepressant treatment: a placebo-controlled trial and a triple-blind one. Neither is large and neither settles the question, but both exist, which is more than most ingredients on this shelf can say.

A creeping marsh herb with a long Ayurvedic history and, unusually for that category, a modern trial record that holds up to pooling. The meta-analysis of its randomised trials found a consistent improvement in the speed of attention tasks at 300 mg a day of a standardised extract.

The number to carry away is not the dose, it is the duration. The twelve-week trial in older adults is the shape most of this evidence takes, and twelve weeks is what the trials waited before measuring. A 2025 trial in healthy adults ran on a similar clock. Bacopa is not an ingredient that reports for duty in a fortnight.

The 2026 network meta-analysis compares bacopa and ginkgo directly and places the band where an effect is measurable at 600 mg a day and above, with 300 to 600 mg as the low-dose comparator. Both of those figures are large for a capsule that also has to hold six other things.

A compound the body synthesises from two amino acids and also takes in from red meat and dairy. Its job inside a cell is transport: it carries long-chain fatty acids into the mitochondria, where they are oxidised. That is why it sits under energy, and it is a description of biochemistry rather than a promise about how an afternoon will feel.

Its relevance to this particular shelf rests on one trial of propionyl-L-carnitine at two grams a day, given alongside prescription sildenafil in men with diabetes. The combination outperformed the medicine alone. What that result belongs to is the combination, and a capsule is not a prescription tablet.

A meta-analysis of carnitine, coenzyme Q10 and selenium in couples with unexplained male infertility is the other body of work worth knowing about. Both literatures work in grams: two grams a day is two thousand milligrams of a single ingredient, which is the figure the dosage discussion on the home page turns on.

The most abundant free amino acid in human plasma, present in ordinary protein foods in quantity, and the least exotic thing on this ingredient list. It is a fuel source for the cells lining the gut and for immune cells, and it becomes conditionally essential under severe physiological stress.

The tolerance study in healthy adults is the one that establishes what an oral serving of it looks like, and it worked in grams per kilogram of body weight: 0.3, 0.6 and 0.9 g/kg. For an average adult that is tens of grams, not hundreds of milligrams.

A review of amino-acid supplement safety covers glutamine alongside carnitine and arginine and finds no kidney signal at ordinary intakes in healthy people. It is a well-tolerated ingredient. What it is not, at any amount a capsule could hold, is a large dose of itself.

The one name here that is not a plant extract. Vinpocetine is made in a laboratory from vincamine, an alkaloid originally isolated from lesser periwinkle, and the review that sets out what it is describes it in exactly those terms. It is sold as a prescription medicine in several countries, where clinical use runs 5 to 10 mg three times a day.

A meta-analysis of vinpocetine in acute ischaemic stroke is the largest recent body of clinical work on it. The research setting is hospital neurology, not everyday male vitality, and nothing in that literature transfers to a once-daily capsule.

A survey of American supplements containing it measured what bottles actually held against what they declared, and a later analysis of cognitive-enhancement products covers the same ground. Both are worth reading by anyone who buys in this category, whatever the bottle.

A yellow-flowered European herb with one of the largest trial records in botanical medicine, all of it in mood rather than in anything this bottle is sold for. The Cochrane review covers major depression, a placebo-controlled trial at 900 mg a day is a representative positive result, and the JAMA trial is a representative null one.

Its presence on a male vitality list is the single most consequential thing about this ingredient panel, and the reason has nothing to do with what it does on its own. Hypericum induces the liver enzymes and transporters that clear a long list of prescription medicines, which lowers their blood concentration and can make them stop working. The 2020 review of that evidence sets out which drug classes are reached.

Hormonal contraceptives are among them, which a systematic review and a randomised trial both examined directly. The label is written for adult men, so that particular combination is unlikely here, but it is the clearest illustration of how far the interaction reaches. Anyone on a prescription should raise this bottle with their prescriber first.

An alkaloid from a Chinese club moss, and the only ingredient on this label whose studied amounts are measured in micrograms rather than milligrams. It inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine, which is the same mechanism a class of prescription dementia medicines uses.

A meta-analysis of its randomised trials in Alzheimer's disease reported improvements on cognitive scales at a few hundred micrograms a day. The Cochrane review in mild cognitive impairment is more cautious about the quality of the underlying studies, which is the honest way to hold both findings at once.

An assay of huperzine A products on sale is the piece that matters most to a buyer. It found meaningful variation between declared and measured content across the market, which is a reason to buy from a channel that will answer a question about a lot number rather than from a marketplace listing.